Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 7 min read

How Inflammaging Changes With Age

Inflammaging is the chronic, low-grade, systemic inflammation that rises with age. This page summarises what the research literature reports about its mechanisms, its tissue-specific signatures, and the models in which t

peptides-pro Editorial

What inflammaging is

Inflammaging is the term used in the geroscience literature for chronic, low-grade, systemic inflammation that increases with chronological age. It is not an acute inflammatory response and it is not a clinical diagnosis; it is a descriptive research construct covering elevated circulating inflammatory mediators, altered immune-cell function, and tissue-level inflammatory signalling observed in older organisms. The literature reviewed here treats it as one of several interacting hallmarks of aging, alongside mitochondrial dysfunction, cellular senescence, and neuromuscular degeneration [3].

No single sequence, formula, or molecular weight defines inflammaging, because it is a state rather than a molecule. The mediators most often measured in the studies cited below are circulating interleukins and myokines, together with plasma antioxidant capacity, which investigators have used to construct an “oxidative/inflammatory signature” in elderly subjects [6]. The pathway families the work centres on are the cytokine and senescence-associated secretory phenotype (SASP) signalling networks, which link senescent cell burden to systemic inflammatory tone [8][10].

Research Studies

Inflammaging and sarcopenia in older adults

A review of sarcopenia biomarkers describes the condition as a progressive age-related skeletal muscle disorder involving loss of muscle mass, strength, and physical performance, and reports that it arises from complex interactions among mitochondrial dysfunction, chronic low-grade inflammation, cellular senescence, neuromuscular junction degeneration, and anabolic resistance [3]. In that framing, inflammaging is not a downstream consequence of muscle loss but one of several co-acting mechanisms. The review notes that the underlying biology remains incompletely understood, which the authors identify as a limit on early diagnostic strategies and targeted therapies [3].

Myokines and the muscle-brain axis

A narrative review synthesising mechanistic and translational evidence reports that sarcopenia and cognitive decline frequently co-occur in older adults and appear to share a biological substrate centred on the muscle-brain axis [2]. Skeletal muscle is reported to communicate with the ageing brain through myokines and exerkines, including irisin/FNDC5, brain-derived neurotrophic factor (BDNF), interleukin-6 (IL-6), insulin-like growth factor-1 (IGF-1), cathepsin B, and growth differentiation factor-15 (GDF-15). Progressive sarcopenia is reported to disrupt this signalling in a way that accelerates cognitive impairment [2]. IL-6 appears in both the muscle and the inflammaging literature, which is one reason the two research lines overlap.

Glucose metabolism, muscle function, and inflammatory signature

A registered clinical study characterises glucose metabolism and inflammaging in elderly subjects in order to determine how each factor affects muscle mass and function and contributes to age-related muscle wasting [6]. The protocol correlates patterns of insulin secretion and sensitivity with muscle quality and quantity in diabetic and non-diabetic participants aged 70 and older, comparing healthy, sarcopenic, diabetic, and diabetic/sarcopenic groups. The stated expectation is to identify an oxidative/inflammatory signature specific to the sarcopenic phenotype and related to muscle insulin resistance [6]. This is a study design, not a reported outcome.

Inflammaging in the heart-brain-bone framework

A review of lipid-soluble nutrients proposes a “Heart-Brain-Bone” axis to organise evidence on cardiovascular disease, neurocognitive decline, and osteoporotic bone loss, which the authors note have historically been managed in isolation [1]. Mechanistic data are reported to couple these systems through shared regulators of calcium trafficking, inflammation resolution, vascular integrity, and inflammaging. The authors are explicit that the axis should be understood as an integrative conceptual framework organising evidence from three separate studies, not as a validated physiological entity with agreed diagnostic criteria or demonstrated modifiability [1].

Nutritional intake and inflammaging markers

A registered study on cardiovascular risk and inflammaging notes prior evidence linking fruit and vegetable consumption to reduced cardiac risk, potentially mediated through effects on blood pressure, platelet function, and vascular reactivity [5]. Certain vitamins and polyphenols found in fruits and vegetables are reported to have antioxidant and anti-inflammatory effects and to play a role in immune cell function. The same body of prior work reports effects of omega-3 fatty acids on the cardiovascular system, blood lipid regulation, and inflammatory response [5]. These are cited as background rationale for the study rather than as its results.

Surgical stress as an acute inflammaging model

A registered trial in older patients undergoing coronary artery bypass grafting describes the surgical stress response in quantitative terms: systemic epinephrine rising 33-fold and norepinephrine rising 3-fold [4]. Local tissue injury is reported to produce sterile inflammation with release of damage-associated molecular patterns (DAMPs), which activate neutrophils and trigger a cascade of cytokines, complement, and coagulation changes. Nociceptor activation is reported to drive a neurometabolic response involving the sympathetic nervous system and the hypothalamus-pituitary axis [4]. CABG is performed in approximately 400,000 patients in the United States each year, making it one of the most common major surgeries in older adults [4]. This model is useful because it compresses an inflammatory trajectory into a defined window, in contrast to the decades-long trajectory of inflammaging.

Vascular aging and senescence-driven inflammation

A review of intracranial aneurysms reports that aging is a major risk factor for their formation, growth, and rupture, and that vascular aging beyond chronological age is driven by cellular senescence, chronic inflammation, and hemodynamic stress [8]. In this framing, aneurysm wall degeneration is treated as a manifestation of premature vascular aging rather than as an isolated structural problem. The finding is reported in the aneurysm literature specifically; it is not a general statement about all vascular beds.

Ovarian aging and systemic inflammaging

A review of ovarian aging and systemic health proposes an ovarian-systemic axis through which ovarian aging may contribute to systemic aging [10]. Intrinsic ovarian cellular defects described include genomic instability, epigenetic shifts, and mitochondrial and proteostasis damage, which may trigger senescence-associated secretory phenotype (SASP)-related inflammaging and fibrosis [10]. As with the vascular work, the observation is made in a specific tissue context and should not be generalised beyond it without further evidence.

Skin aging signatures

A review of skin aging describes it as a multifactorial, dynamically regulated process modulated by intrinsic genetic programming and extrinsic environmental stressors [9]. Chronological skin aging is reported to be dominated by molecular signatures including telomere attrition, mitochondrial dysfunction, and epigenetic drift [9]. This is a tissue-specific instance of the broader pattern in which senescence and inflammatory signalling co-occur with age.

Comparison of reported tissue contexts

Tissue or modelInflammaging-linked feature reportedSource
Skeletal muscle (sarcopenia)Chronic low-grade inflammation, mitochondrial dysfunction, cellular senescence, anabolic resistance[3]
Muscle-brain axisMyokine and exerkine signalling including IL-6, BDNF, irisin/FNDC5, GDF-15[2]
Elderly glucose metabolism cohortOxidative/inflammatory signature correlated with muscle insulin resistance[6]
Vascular wall (intracranial aneurysm)Cellular senescence, chronic inflammation, hemodynamic stress[8]
OvarySASP-related inflammaging and fibrosis[10]
SkinTelomere attrition, mitochondrial dysfunction, epigenetic drift[9]
Post-CABG surgical stressDAMP release, neutrophil activation, cytokine and complement cascade[4]

Where the evidence is animal-only or in vitro

The sources cited here are reviews, narrative syntheses, and registered study protocols. Several report mechanistic data without specifying that the findings were obtained in humans; where a review synthesises “mechanistic and translational evidence,” the mechanistic portion is typically derived from cell and animal models [2]. The registered studies [4][5][6] describe planned or ongoing human protocols and therefore report no outcomes. Readers should treat mechanism-level claims in this area as model-dependent until human interventional data are available.

If you are reading this for personal health reasons

The materials described on this page are sold for laboratory research use only. We do not provide dosing information, medical guidance, or recommendations for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

WhatsApp